Current Status of COVID-19 Among Hemodialysis Patients in the East Azerbaijan Province of Iran

Overview

Journal Hemodial Int

Date 2020 Dec 4

PMID 33275317

Citations 5

Authors

Hamid Tayebi Khosroshahi

Alireza Mardomi

Bahram Niknafs

Farahnoosh Farnood

Mohsen Shekarchi

Shabnam Salehi

Taghi Fadaei Haggi

Affiliations

Soon will be listed here.

Abstract

Introduction: Management of vulnerable patients during the COVID-19 pandemic requires careful precautions. Hemodialysis patients constitute a large group of at-risk patients that not only suffer from a compromised immune system but also are at a higher risk due to frequent admission to healthcare units. Therefore, a better understanding on the pathogenesis and possible risk factors of COVID-19 in hemodialysis patients is of high importance.

Methods: A total of 670 maintained hemodialysis patients from all dialysis units of the East Azerbaijan Province of Iran, including 44 COVID-19 patients were included in the present study. Possible associations between the backgrounds of patients and the incidence of COVID-19 were assessed. Also, hemodialysis patients with COVID-19 were compared to 211 nonhemodialysis COVID-19 patients.

Findings: Chronic glomerulonephritis patients and those with blood group A demonstrated a higher incidence of COVID-19. On the other hand, patients with blood group AB and those with hypertension etiology of kidney failure demonstrated a lower incidence of COVID-19. Hemodialysis patients with COVID-19 had higher counts of polymorphonuclears (PMNs) in their peripheral blood compared to other COVID-19 patients.

Discussion: A better comprehension on the risk factors associated with COVID-19 in hemodialysis patients can improve our understanding on the pathogenesis of COVID-19 in different situations and help the enhancement of current therapeutics for COVID-19 in hemodialysis patients.

Citing Articles

Prognosis of COVID-19 in the middle eastern population, knowns and unknowns.

Dandachi I, Aljabr W Front Microbiol. 2022; 13:974205.

PMID: 36118201 PMC: 9471247. DOI: 10.3389/fmicb.2022.974205.

Mortality and risk factors for COVID-19 in hemodialysis patients: A systematic review and meta-analysis.

Li P, Guan Y, Zhou S, Wang E, Sun P, Fei G Sci Prog. 2022; 105(3):368504221110858.

PMID: 35775141 PMC: 10358525. DOI: 10.1177/00368504221110858.

The Role of ABO Blood Type in Patients with SARS-CoV-2 Infection: A Systematic Review.

Banchelli F, Negro P, Guido M, DAmico R, Fittipaldo V, Grima P J Clin Med. 2022; 11(11).

PMID: 35683418 PMC: 9181227. DOI: 10.3390/jcm11113029.

The Global Impact of the COVID-19 Pandemic on In-Center Hemodialysis Services: An ISN-Dialysis Outcomes Practice Patterns Study Survey.

Aylward R, Bieber B, Guedes M, Pisoni R, Tannor E, Dreyer G Kidney Int Rep. 2021; 7(3):397-409.

PMID: 34957349 PMC: 8684834. DOI: 10.1016/j.ekir.2021.12.011.

The frail world of haemodialysis patients in the COVID-19 pandemic era: a systematic scoping review.

Alfano G, Ferrari A, Magistroni R, Fontana F, Cappelli G, Basile C J Nephrol. 2021; 34(5):1387-1403.

PMID: 34417996 PMC: 8379591. DOI: 10.1007/s40620-021-01136-5.

References

Li J, Yang Y, Gong M, Shi J, Zhou X, Xing X . Aggressive Quarantine Measures Reduce the High Morbidity of COVID-19 in Patients on Maintenance Hemodialysis and Medical Staff of Hemodialysis Facilities in Wuhan, China. Kidney Dis (Basel). 2020; 6(4):271-283. PMC: 7316663. DOI: 10.1159/000508579. View

Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z . Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020; 395(10229):1054-1062. PMC: 7270627. DOI: 10.1016/S0140-6736(20)30566-3. View

Sardenberg C, Suassuna P, Andreoli M, Watanabe R, Dalboni M, Manfredi S . Effects of uraemia and dialysis modality on polymorphonuclear cell apoptosis and function. Nephrol Dial Transplant. 2005; 21(1):160-5. DOI: 10.1093/ndt/gfi095. View

Palmer S, Tunnicliffe D, Singh-Grewal D, Mavridis D, Tonelli M, Johnson D . Induction and Maintenance Immunosuppression Treatment of Proliferative Lupus Nephritis: A Network Meta-analysis of Randomized Trials. Am J Kidney Dis. 2017; 70(3):324-336. DOI: 10.1053/j.ajkd.2016.12.008. View

Sharif M, Chitsazian Z, Moosavian M, Raygan F, Nikoueinejad H, Sharif A . Immune disorders in hemodialysis patients. Iran J Kidney Dis. 2015; 9(2):84-96. View

Skendros P, Mitsios A, Chrysanthopoulou A, Mastellos D, Metallidis S, Rafailidis P . Complement and tissue factor-enriched neutrophil extracellular traps are key drivers in COVID-19 immunothrombosis. J Clin Invest. 2020; 130(11):6151-6157. PMC: 7598040. DOI: 10.1172/JCI141374. View

Monti S, Balduzzi S, Delvino P, Bellis E, Quadrelli V, Montecucco C . Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies. Ann Rheum Dis. 2020; 79(5):667-668. PMC: 7211079. DOI: 10.1136/annrheumdis-2020-217424. View

Mastellos D, Reis E, Biglarnia A, Waldman M, Quigg R, Huber-Lang M . Taming hemodialysis-induced inflammation: Are complement C3 inhibitors a viable option?. Clin Immunol. 2018; 198:102-105. PMC: 7366512. DOI: 10.1016/j.clim.2018.11.010. View

Wang R, Liao C, He H, Hu C, Wei Z, Hong Z . COVID-19 in Hemodialysis Patients: A Report of 5 Cases. Am J Kidney Dis. 2020; 76(1):141-143. PMC: 7118604. DOI: 10.1053/j.ajkd.2020.03.009. View

10.

Kuroki Y, Tsuchida K, Go I, Aoyama M, Naganuma T, Takemoto Y . A study of innate immunity in patients with end-stage renal disease: special reference to toll-like receptor-2 and -4 expression in peripheral blood monocytes of hemodialysis patients. Int J Mol Med. 2007; 19(5):783-90. View

11.

Zuo Y, Yalavarthi S, Shi H, Gockman K, Zuo M, Madison J . Neutrophil extracellular traps in COVID-19. JCI Insight. 2020; 5(11). PMC: 7308057. DOI: 10.1172/jci.insight.138999. View

12.

Lim W, Kireta S, Leedham E, Russ G, Coates P . Uremia impairs monocyte and monocyte-derived dendritic cell function in hemodialysis patients. Kidney Int. 2007; 72(9):1138-48. DOI: 10.1038/sj.ki.5002425. View

13.

Eleftheriadis T, Liakopoulos V, Leivaditis K, Antoniadi G, Stefanidis I . Infections in hemodialysis: a concise review. Part II: blood transmitted viral infections. Hippokratia. 2011; 15(2):120-6. PMC: 3209673. View

14.

Ke C, Wang Y, Zeng X, Yang C, Hu Z . 2019 Novel coronavirus disease (COVID-19) in hemodialysis patients: A report of two cases. Clin Biochem. 2020; 81:9-12. PMC: 7191272. DOI: 10.1016/j.clinbiochem.2020.04.008. View

15.

Zhang J, Wang X, Jia X, Li J, Hu K, Chen G . Risk factors for disease severity, unimprovement, and mortality in COVID-19 patients in Wuhan, China. Clin Microbiol Infect. 2020; 26(6):767-772. PMC: 7159868. DOI: 10.1016/j.cmi.2020.04.012. View

16.

Tang B, Li S, Xiong Y, Tian M, Yu J, Xu L . COVID-19 Pneumonia in a Hemodialysis Patient. Kidney Med. 2020; 2(3):354-358. PMC: 7103984. DOI: 10.1016/j.xkme.2020.03.001. View

17.

Gedney N . Long-Term Hemodialysis during the COVID-19 Pandemic. Clin J Am Soc Nephrol. 2020; 15(8):1073-1074. PMC: 7409751. DOI: 10.2215/CJN.09100620. View

18.

Liu Y, Du X, Chen J, Jin Y, Peng L, Wang H . Neutrophil-to-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19. J Infect. 2020; 81(1):e6-e12. PMC: 7195072. DOI: 10.1016/j.jinf.2020.04.002. View

19.

Middleton E, He X, Denorme F, Campbell R, Ng D, Salvatore S . Neutrophil extracellular traps contribute to immunothrombosis in COVID-19 acute respiratory distress syndrome. Blood. 2020; 136(10):1169-1179. PMC: 7472714. DOI: 10.1182/blood.2020007008. View

20.

Wu T, Lim P, Jin J, Wu M, Chen C . Impaired Gut Epithelial Tight Junction Expression in Hemodialysis Patients Complicated with Intradialytic Hypotension. Biomed Res Int. 2018; 2018:2670312. PMC: 5822862. DOI: 10.1155/2018/2670312. View